These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10751541)

  • 1. Advances in immunopharmacology of asthma.
    Wong WS; Koh DS
    Biochem Pharmacol; 2000 Jun; 59(11):1323-35. PubMed ID: 10751541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inflammatory cytokines (IL-4, IL-5 and IL-13)].
    Maeda S; Yanagihara Y
    Nihon Rinsho; 2001 Oct; 59(10):1894-9. PubMed ID: 11676128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agents against cytokine synthesis or receptors.
    Yamagata T; Ichinose M
    Eur J Pharmacol; 2006 Mar; 533(1-3):289-301. PubMed ID: 16457805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ginsenoside Rh2 attenuates allergic airway inflammation by modulating nuclear factor-κB activation in a murine model of asthma.
    Li LC; Piao HM; Zheng MY; Lin ZH; Choi YH; Yan GH
    Mol Med Rep; 2015 Nov; 12(5):6946-54. PubMed ID: 26502836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Th2 cells in asthmatic airways.
    Caramori G; Ito K; Adcock IM
    Curr Drug Targets Inflamm Allergy; 2004 Sep; 3(3):243-55. PubMed ID: 15379592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Citrus tachibana Leaves Ethanol Extract Alleviates Airway Inflammation by the Modulation of Th1/Th2 Imbalance via Inhibiting NF-κB Signaling and Histamine Secretion in a Mouse Model of Allergic Asthma.
    Bui TT; Piao CH; Kim SM; Song CH; Shin HS; Lee CH; Chai OH
    J Med Food; 2017 Jul; 20(7):676-684. PubMed ID: 28598706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18β-Glycyrrhetinic acid, the major bioactive component of Glycyrrhizae Radix, attenuates airway inflammation by modulating Th2 cytokines, GATA-3, STAT6, and Foxp3 transcription factors in an asthmatic mouse model.
    Kim SH; Hong JH; Lee JE; Lee YC
    Environ Toxicol Pharmacol; 2017 Jun; 52():99-113. PubMed ID: 28410469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on biologic-based therapy in asthma.
    Walsh GM
    Immunotherapy; 2013 Nov; 5(11):1255-64. PubMed ID: 24188679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiallergic asthma properties of brazilin through inhibition of TH2 responses in T cells and in a murine model of asthma.
    Lee CC; Wang CN; Kang JJ; Liao JW; Chiang BL; Chen HC; Hu CM; Lin CD; Huang SH; Lai YT
    J Agric Food Chem; 2012 Sep; 60(37):9405-14. PubMed ID: 22920671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of histamine on Th1/Th2 cytokine balance.
    Packard KA; Khan MM
    Int Immunopharmacol; 2003 Jul; 3(7):909-20. PubMed ID: 12810348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ursolic acid, a potential PPARγ agonist, suppresses ovalbumin-induced airway inflammation and Penh by down-regulating IL-5, IL-13, and IL-17 in a mouse model of allergic asthma.
    Kim SH; Hong JH; Lee YC
    Eur J Pharmacol; 2013 Feb; 701(1-3):131-43. PubMed ID: 23201068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Cytokines of Asthma.
    Lambrecht BN; Hammad H; Fahy JV
    Immunity; 2019 Apr; 50(4):975-991. PubMed ID: 30995510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-5 and IL-5 receptor in asthma.
    Kotsimbos AT; Hamid Q
    Mem Inst Oswaldo Cruz; 1997; 92 Suppl 2():75-91. PubMed ID: 9698919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into the role of cytokines in asthma.
    Renauld JC
    J Clin Pathol; 2001 Aug; 54(8):577-89. PubMed ID: 11477111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphodiesterase inhibitors in airways disease.
    Fan Chung K
    Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-asthmatic effect of schizandrin on OVA-induced airway inflammation in a murine asthma model.
    Lee MY; Seo CS; Lee NH; Ha H; Lee JA; Lee H; Lee KY; Shin HK
    Int Immunopharmacol; 2010 Nov; 10(11):1374-9. PubMed ID: 20727999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. meso-Dihydroguaiaretic acid attenuates airway inflammation and mucus hypersecretion in an ovalbumin-induced murine model of asthma.
    Song JW; Seo CS; Cho ES; Kim TI; Won YS; Kwon HJ; Son JK; Son HY
    Int Immunopharmacol; 2016 Feb; 31():239-47. PubMed ID: 26773771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New anti-asthma therapies: suppression of the effect of interleukin (IL)-4 and IL-5.
    Kips JC; Tournoy KG; Pauwels RA
    Eur Respir J; 2001 Mar; 17(3):499-506. PubMed ID: 11405532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Childhood asthma as an allergic disease: rationale for the development of future treatment.
    Tang ML; Powell CV
    Eur J Pediatr; 2001 Dec; 160(12):696-704. PubMed ID: 11795676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BuShenYiQi Formula strengthens Th1 response and suppresses Th2-Th17 responses in RSV-induced asthma exacerbated mice.
    Wang J; Wu J; Kong L; Nurahmat M; Chen M; Luo Q; Li B; Wu X; Dong J
    J Ethnopharmacol; 2014 May; 154(1):131-47. PubMed ID: 24704667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.